Healthy male
Conditions
Interventions
Intake of the standard products,Intake of the test products
Sponsors
TTC Co.,Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1)Males from 20 to 50 years of age. (2)Subjects who have a difference of incremental area under the curve of plasma glucose levels between preliminary examination 1 and preliminary examination 2 within 25 percent.
Exclusion criteria
Exclusion criteria: (1)Subjects routinely taking medicine or health food which may influence glucose metabolism. (2)Subjects who have abnormal glucose tolerance within the one month prior on preliminary examination. (3)Subjects who have body mass index (BMI) less than 18.5 kg per square meter or more than 25.0 kg per square meter. (4)Subjects who have abnormal glucose tolerance on preliminary examination (5)Subjects who work at night or have irregular life more than one time in the study. (6)Subjects who are planning to go overseas. (7)Subjects with allergies to the test food in the study. (8)Subjects who drink alcohol a lot. (9)Subjects who smoke a lot. (10)Subjects who has serious illness such as diabetes, liver disease, kidney disease, heart disease, digestive system disease. (11)Subjects who have a disease under medication or having a history of study such as obesity, dyslipidemia, hypertension or who has a serious disease. (12)Subject who are judged as unsuitable for the study from clinical measurements for preliminary tests and measurements. (13)Subjects who have participated in other clinical study within the last one month or have planned to participate other clinical studies. (14)Subjects who are judged as unsuitable for the study from questionnaire. (15)Subjects who are judged as ineligible by clinical investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incremental area under the curve of plasma glucose | — |
Secondary
| Measure | Time frame |
|---|---|
| Peak in plasma glucose concentration, fasting plasma glucose , plasma glucose at 15, 30, 45, 60, 90, and 120 min. | — |
Countries
Japan
Contacts
Public ContactNoriko Watanabe
TTC Co.,Ltd. Clinical Research Planning Department
Outcome results
None listed